Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer

SIMPLE SUMMARY: Using a first-principles approach, we demonstrate how standard-of-care therapies for bone metastatic prostate cancer (BMPCa) patients can be optimized with the use of routine measurements to significantly delay the evolution of resistant disease, potentially extending overall patient...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Araujo, Arturo, Cook, Leah M., Frieling, Jeremy S., Tan, Winston, Copland, John A., Kohli, Manish, Gupta, Shilpa, Dhillon, Jasreman, Pow-Sang, Julio, Lynch, Conor C., Basanta, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7915310/
https://ncbi.nlm.nih.gov/pubmed/33567529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040677
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg